IT1401504B1 - Composizione comprendente glutatione reduttasi e glutatione ossidato - Google Patents

Composizione comprendente glutatione reduttasi e glutatione ossidato

Info

Publication number
IT1401504B1
IT1401504B1 ITMI2010A001459A ITMI20101459A IT1401504B1 IT 1401504 B1 IT1401504 B1 IT 1401504B1 IT MI2010A001459 A ITMI2010A001459 A IT MI2010A001459A IT MI20101459 A ITMI20101459 A IT MI20101459A IT 1401504 B1 IT1401504 B1 IT 1401504B1
Authority
IT
Italy
Prior art keywords
glutation
reductase
oxidized
composition including
composition
Prior art date
Application number
ITMI2010A001459A
Other languages
English (en)
Inventor
Raffaele Ansovini
Original Assignee
Cattarini Mastelli
Ansovini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cattarini Mastelli, Ansovini filed Critical Cattarini Mastelli
Priority to ITMI2010A001459A priority Critical patent/IT1401504B1/it
Priority to PCT/IB2011/053390 priority patent/WO2012017367A1/en
Priority to US13/813,426 priority patent/US8852582B2/en
Priority to EP11754493.2A priority patent/EP2600883A1/en
Priority to CN2011800383817A priority patent/CN103167877A/zh
Priority to RU2013109361/15A priority patent/RU2013109361A/ru
Priority to KR1020137005587A priority patent/KR20140015246A/ko
Publication of ITMI20101459A1 publication Critical patent/ITMI20101459A1/it
Application granted granted Critical
Publication of IT1401504B1 publication Critical patent/IT1401504B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01007—Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ITMI2010A001459A 2010-08-02 2010-08-02 Composizione comprendente glutatione reduttasi e glutatione ossidato IT1401504B1 (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
ITMI2010A001459A IT1401504B1 (it) 2010-08-02 2010-08-02 Composizione comprendente glutatione reduttasi e glutatione ossidato
PCT/IB2011/053390 WO2012017367A1 (en) 2010-08-02 2011-07-29 Composition comprising glutathione reductase and oxidized glutathione, and therapeutic uses thereof
US13/813,426 US8852582B2 (en) 2010-08-02 2011-07-29 Compositions comprising glutathione reductase and oxidized glutathione
EP11754493.2A EP2600883A1 (en) 2010-08-02 2011-07-29 Composition comprising glutathione reductase and oxidized glutathione, and therapeutic uses thereof
CN2011800383817A CN103167877A (zh) 2010-08-02 2011-07-29 包含谷胱甘肽还原酶和氧化型谷胱甘肽的组合物，以及其治疗用途
RU2013109361/15A RU2013109361A (ru) 2010-08-02 2011-07-29 Композиция, содержащая глутатионредуктазу и окисленный глутатион, и ее терапевтическое применение
KR1020137005587A KR20140015246A (ko) 2010-08-02 2011-07-29 글루타티온 환원효소 및 산화된 글루타티온을 포함하는 조성물, 및 이의 치료학적 용도

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2010A001459A IT1401504B1 (it) 2010-08-02 2010-08-02 Composizione comprendente glutatione reduttasi e glutatione ossidato

Publications (2)

Publication Number Publication Date
ITMI20101459A1 ITMI20101459A1 (it) 2012-02-03
IT1401504B1 true IT1401504B1 (it) 2013-07-26

Family

ID=43739490

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2010A001459A IT1401504B1 (it) 2010-08-02 2010-08-02 Composizione comprendente glutatione reduttasi e glutatione ossidato

Country Status (7)

Country Link
US (1) US8852582B2 (it)
EP (1) EP2600883A1 (it)
KR (1) KR20140015246A (it)
CN (1) CN103167877A (it)
IT (1) IT1401504B1 (it)
RU (1) RU2013109361A (it)
WO (1) WO2012017367A1 (it)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2925546C (en) 2012-10-29 2022-06-14 The University Of North Carolina At Chapel Hill Methods and compositions for treating mucosal tissue disorders
US10163479B2 (en) 2015-08-14 2018-12-25 Spin Transfer Technologies, Inc. Method and apparatus for bipolar memory write-verify
US10818331B2 (en) 2016-09-27 2020-10-27 Spin Memory, Inc. Multi-chip module for MRAM devices with levels of dynamic redundancy registers
US10546625B2 (en) 2016-09-27 2020-01-28 Spin Memory, Inc. Method of optimizing write voltage based on error buffer occupancy
US11119936B2 (en) 2016-09-27 2021-09-14 Spin Memory, Inc. Error cache system with coarse and fine segments for power optimization
US10366774B2 (en) 2016-09-27 2019-07-30 Spin Memory, Inc. Device with dynamic redundancy registers
US11119910B2 (en) 2016-09-27 2021-09-14 Spin Memory, Inc. Heuristics for selecting subsegments for entry in and entry out operations in an error cache system with coarse and fine grain segments
US11151042B2 (en) 2016-09-27 2021-10-19 Integrated Silicon Solution, (Cayman) Inc. Error cache segmentation for power reduction
US10460781B2 (en) 2016-09-27 2019-10-29 Spin Memory, Inc. Memory device with a dual Y-multiplexer structure for performing two simultaneous operations on the same row of a memory bank
US10360964B2 (en) 2016-09-27 2019-07-23 Spin Memory, Inc. Method of writing contents in memory during a power up sequence using a dynamic redundancy register in a memory device
US10991410B2 (en) 2016-09-27 2021-04-27 Spin Memory, Inc. Bi-polar write scheme
US10446210B2 (en) 2016-09-27 2019-10-15 Spin Memory, Inc. Memory instruction pipeline with a pre-read stage for a write operation for reducing power consumption in a memory device that uses dynamic redundancy registers
US10437723B2 (en) 2016-09-27 2019-10-08 Spin Memory, Inc. Method of flushing the contents of a dynamic redundancy register to a secure storage area during a power down in a memory device
US10437491B2 (en) 2016-09-27 2019-10-08 Spin Memory, Inc. Method of processing incomplete memory operations in a memory device during a power up sequence and a power down sequence using a dynamic redundancy register
US10628316B2 (en) 2016-09-27 2020-04-21 Spin Memory, Inc. Memory device with a plurality of memory banks where each memory bank is associated with a corresponding memory instruction pipeline and a dynamic redundancy register
AU2017362500B2 (en) 2016-11-17 2024-09-26 Renovion, Inc. Treatment of Respiratory Tract Diseases and Infections with Ascorbic Acid Compositions
US10489245B2 (en) 2017-10-24 2019-11-26 Spin Memory, Inc. Forcing stuck bits, waterfall bits, shunt bits and low TMR bits to short during testing and using on-the-fly bit failure detection and bit redundancy remapping techniques to correct them
US10656994B2 (en) 2017-10-24 2020-05-19 Spin Memory, Inc. Over-voltage write operation of tunnel magnet-resistance (“TMR”) memory device and correcting failure bits therefrom by using on-the-fly bit failure detection and bit redundancy remapping techniques
US10529439B2 (en) 2017-10-24 2020-01-07 Spin Memory, Inc. On-the-fly bit failure detection and bit redundancy remapping techniques to correct for fixed bit defects
US10481976B2 (en) 2017-10-24 2019-11-19 Spin Memory, Inc. Forcing bits as bad to widen the window between the distributions of acceptable high and low resistive bits thereby lowering the margin and increasing the speed of the sense amplifiers
RU2659161C1 (ru) * 2017-11-17 2018-06-28 Общество С Ограниченной Ответственностью "Ива Фарм" Фармацевтическая композиция, включающая дисульфид глутатиона и глутатион дисульфид s-оксид
WO2019099946A1 (en) 2017-11-17 2019-05-23 Renovion, Inc. Stable ascorbic acid compositions and methods of using the same
US10679685B2 (en) 2017-12-27 2020-06-09 Spin Memory, Inc. Shared bit line array architecture for magnetoresistive memory
US10395711B2 (en) 2017-12-28 2019-08-27 Spin Memory, Inc. Perpendicular source and bit lines for an MRAM array
US10424726B2 (en) 2017-12-28 2019-09-24 Spin Memory, Inc. Process for improving photoresist pillar adhesion during MRAM fabrication
US10360962B1 (en) 2017-12-28 2019-07-23 Spin Memory, Inc. Memory array with individually trimmable sense amplifiers
US10395712B2 (en) 2017-12-28 2019-08-27 Spin Memory, Inc. Memory array with horizontal source line and sacrificial bitline per virtual source
US10811594B2 (en) 2017-12-28 2020-10-20 Spin Memory, Inc. Process for hard mask development for MRAM pillar formation using photolithography
US10891997B2 (en) 2017-12-28 2021-01-12 Spin Memory, Inc. Memory array with horizontal source line and a virtual source line
US10840436B2 (en) 2017-12-29 2020-11-17 Spin Memory, Inc. Perpendicular magnetic anisotropy interface tunnel junction devices and methods of manufacture
US10840439B2 (en) 2017-12-29 2020-11-17 Spin Memory, Inc. Magnetic tunnel junction (MTJ) fabrication methods and systems
US10886330B2 (en) 2017-12-29 2021-01-05 Spin Memory, Inc. Memory device having overlapping magnetic tunnel junctions in compliance with a reference pitch
US10424723B2 (en) 2017-12-29 2019-09-24 Spin Memory, Inc. Magnetic tunnel junction devices including an optimization layer
US10784439B2 (en) 2017-12-29 2020-09-22 Spin Memory, Inc. Precessional spin current magnetic tunnel junction devices and methods of manufacture
US10546624B2 (en) 2017-12-29 2020-01-28 Spin Memory, Inc. Multi-port random access memory
US10367139B2 (en) 2017-12-29 2019-07-30 Spin Memory, Inc. Methods of manufacturing magnetic tunnel junction devices
US10438996B2 (en) 2018-01-08 2019-10-08 Spin Memory, Inc. Methods of fabricating magnetic tunnel junctions integrated with selectors
US10438995B2 (en) 2018-01-08 2019-10-08 Spin Memory, Inc. Devices including magnetic tunnel junctions integrated with selectors
US10446744B2 (en) 2018-03-08 2019-10-15 Spin Memory, Inc. Magnetic tunnel junction wafer adaptor used in magnetic annealing furnace and method of using the same
US10388861B1 (en) 2018-03-08 2019-08-20 Spin Memory, Inc. Magnetic tunnel junction wafer adaptor used in magnetic annealing furnace and method of using the same
US11107978B2 (en) 2018-03-23 2021-08-31 Spin Memory, Inc. Methods of manufacturing three-dimensional arrays with MTJ devices including a free magnetic trench layer and a planar reference magnetic layer
US20190296220A1 (en) 2018-03-23 2019-09-26 Spin Transfer Technologies, Inc. Magnetic Tunnel Junction Devices Including an Annular Free Magnetic Layer and a Planar Reference Magnetic Layer
US11107974B2 (en) 2018-03-23 2021-08-31 Spin Memory, Inc. Magnetic tunnel junction devices including a free magnetic trench layer and a planar reference magnetic layer
US10784437B2 (en) 2018-03-23 2020-09-22 Spin Memory, Inc. Three-dimensional arrays with MTJ devices including a free magnetic trench layer and a planar reference magnetic layer
US10411185B1 (en) 2018-05-30 2019-09-10 Spin Memory, Inc. Process for creating a high density magnetic tunnel junction array test platform
US10593396B2 (en) 2018-07-06 2020-03-17 Spin Memory, Inc. Multi-bit cell read-out techniques for MRAM cells with mixed pinned magnetization orientations
US10600478B2 (en) 2018-07-06 2020-03-24 Spin Memory, Inc. Multi-bit cell read-out techniques for MRAM cells with mixed pinned magnetization orientations
US10559338B2 (en) 2018-07-06 2020-02-11 Spin Memory, Inc. Multi-bit cell read-out techniques
US10692569B2 (en) 2018-07-06 2020-06-23 Spin Memory, Inc. Read-out techniques for multi-bit cells
US10650875B2 (en) 2018-08-21 2020-05-12 Spin Memory, Inc. System for a wide temperature range nonvolatile memory
US10699761B2 (en) 2018-09-18 2020-06-30 Spin Memory, Inc. Word line decoder memory architecture
US10971680B2 (en) 2018-10-01 2021-04-06 Spin Memory, Inc. Multi terminal device stack formation methods
US11621293B2 (en) 2018-10-01 2023-04-04 Integrated Silicon Solution, (Cayman) Inc. Multi terminal device stack systems and methods
US11107979B2 (en) 2018-12-28 2021-08-31 Spin Memory, Inc. Patterned silicide structures and methods of manufacture
US20240139277A1 (en) * 2020-05-20 2024-05-02 Tohoku University Drug containing active sulfur compound as its main component
MX2024008001A (es) 2022-01-04 2024-07-12 Renovion Inc Solucion acuosa que comprende una sal de glutation.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281353A (en) * 1991-04-24 1994-01-25 Allergan, Inc. Compositions and methods for disinfecting/cleaning of lenses and for destroying oxidative disinfectants
US6251857B1 (en) * 1995-12-14 2001-06-26 Novelos Therapeutics, Inc. Cytokine and hemopoietic factor endogenous production enhancer and methods of use thereof
IT1284139B1 (it) * 1996-09-06 1998-05-08 Acraf Composizione farmaceutica comprendente un coenzima utile nel trattamento della sindrome da immunodeficenza acquisita
DE69841217D1 (de) * 1997-01-13 2009-11-19 Univ Emory Glutathion zur behandlung von influenzainfektionen
IT1312569B1 (it) * 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
CN1253832A (zh) 1999-12-02 2000-05-24 石强 肝衰代谢支持剂及其制备方法
WO2002062978A1 (en) 2001-02-05 2002-08-15 David Holzer Method and composition for in situ metabolizing of glutathione and nad
US20030073618A1 (en) * 2001-02-08 2003-04-17 Kozhemyakin Leonid A. Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof
ITMI20010760A1 (it) 2001-04-10 2002-10-10 Raffaele Ansovini Associazione di enzimi coadiuvante nella terapia con interferone
US20080221029A1 (en) 2002-10-31 2008-09-11 Regents Of The University Of Colorado Methods for treatment of thiol-containing compound deficient conditions
ITTO20031048A1 (it) * 2003-12-30 2005-06-30 Umberto Benatti Derivati del glutatione e loro utilizzi per il trattamento di malattie virali.
US20100310541A1 (en) 2007-05-25 2010-12-09 Ironwood Pharmaceuticals, Inc. Compositions and Methods for Reducing the Toxicity of Certain Toxins

Also Published As

Publication number Publication date
US20130216514A1 (en) 2013-08-22
CN103167877A (zh) 2013-06-19
RU2013109361A (ru) 2014-09-10
ITMI20101459A1 (it) 2012-02-03
EP2600883A1 (en) 2013-06-12
US8852582B2 (en) 2014-10-07
KR20140015246A (ko) 2014-02-06
WO2012017367A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
IT1401504B1 (it) Composizione comprendente glutatione reduttasi e glutatione ossidato
NL350111I2 (nl) fenpicoxamid en prothioconazool
BR112013010725A2 (pt) método, e, composição
BR112012017441A2 (pt) compostos e métodos
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BR112012031855A2 (pt) composição e artigo
BR112012031667A2 (pt) composição
FI20100257A0 (fi) Menetelmä ja hissijärjestely
BR112012027165A2 (pt) composição e artigo
BR112012032683A2 (pt) composição
FI20096058A0 (fi) Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä
HK1223925A1 (zh) 醛糖還原酶抑制劑及其用途
BR112013003536A2 (pt) composição, e utilização de uma composição.
BR112012032980A2 (pt) composição
BR112013002544A2 (pt) seção de armario e armario
BRPI0822725A8 (pt) mancal flangeado e flange
DE112011103058A5 (de) Trepanieroptik
BR112013013352A2 (pt) instalação e mistura e método
DK2553004T3 (da) Sammensatte materialer
FR2964937B1 (fr) Triporteur et direction de triporteur
FI20105853A0 (fi) Liukuohjain ja liukuohjaimella varustettu hissi
BR112012021749A2 (pt) processos e compostos
BR112012029669A2 (pt) composição e método
BRPI1011982A2 (pt) combinações de flubendiamidas e organismos úteis.
BR112013008812A2 (pt) composição e método